ReviewPharmaceuticals (Basel, Switzerland)2025

Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis.

Alexandra-Eleftheria Menni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.